APA (7th ed.) Citation

Tian, H., & Wan, C. Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: A systematic review and meta-analysis. BMC.

Chicago Style (17th ed.) Citation

Tian, Hengyu, and Chidan Wan. Comparative Efficacy and Safety of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Alone in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. BMC.

MLA (9th ed.) Citation

Tian, Hengyu, and Chidan Wan. Comparative Efficacy and Safety of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Alone in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. BMC.

Warning: These citations may not always be 100% accurate.